1. Influenza Viruses & Vaccines
- May 18
- 1 min read
Song, J.-H., Son, S.-E., Kim, H.-W., Kim, S.-J., An, S.-H., Lee, C.-Y., Choi, K.-S., & Kwon, H.-J. (2025). Development of an H9N2 vaccine strain with enhanced neuraminidase immunogenicity via dual hemagglutinin and neuraminidase modification. Journal of Veterinary Science, 26(6), e81. https://doi.org/10.4142/jvs.25069 |
Song, J.-H., Son, S.-E., Kim, H.-W., An, S.-H., Lee, C.-Y., Kwon, H.-J., & Choi, K.-S. (2025). A model H5N2 vaccine strain for dual protection against H5N1 and H9N2 avian influenza viruses. Vaccines, 13(1), 22. https://doi.org/10.3390/vaccines13010022 |
Song, J.-H., Son, S.-E., Kim, H.-W., Kim, S.-J., An, S.-H., Lee, C.-Y., Choi, K.-S., & Kwon, H.-J. (2025). Intranasally administered whole virion inactivated vaccine against clade 2.3.4.4b H5N1 influenza virus with optimized antigen and increased cross-protection. Vaccine, 43(3), 126432. https://doi.org/10.1186/s12985-025-02760-4 |
Son, S.-E., Song, J.-H., Kim, H.-W., An, S.-H., Kim, S.-J., Lee, C.-Y., Kwon, H.-J., & Choi, K.-S. (2025). A high-yield recombinant inactivated whole-virion nasal influenza A(H1N1)pdm09 virus vaccine with an attenuated PB2 gene. International Journal of Molecular Sciences, 26(12), 5489. https://doi.org/10.3390/ijms26125489 |
Son, S.-E., An, S.-H., Lee, C.-Y., Song, J.-H., Kim, H.-W., Kim, S.-J., Hong, S.-M., Kwon, H.-J., & Choi, K.-S. (2025). Evolutionary trajectories and zoonotic potential of a PB2 mutation triad (I147T, K339T, and A588T) in avian influenza viruses. Veterinary Research, 56(1), 24. https://doi.org/10.1186/s13567-025-01680-z |
Son, S.-E., Song, J.-H., An, S.-H., Lee, C.-Y., Kim, I.-H., Kim, H.-W., Choi, K.-S., & Kwon, H.-J. (2025). Genetic optimization of early 2009 pandemic H1N1 vaccine strains for improved replication in embryonated chicken eggs. Journal of Microbiology and Biotechnology, 35(2), 112–120. https://doi.org/10.4014/jmb.2510.10027 |
Comments